Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology I JXC > 2013-08-26 Autonomic Pharmacology > Flashcards

2013-08-26 Autonomic Pharmacology Flashcards

1
Q

Draw out how NE is synthesized, stored and released.

–Where do metyrosine, reserpine, guanethidine Cocaine, and TCAs work?

A

see slide 16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Draw out how ACh is synthesized, stored and released.

–Where do vesamicol, botullinum, and cholinesterase inhibitors act?

A

see slide 15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where do parasympathetic neurons exit the spinal cord?

A

craniosacral

III, VII, IX, X
S2, S3, S4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where do sympathetic neurons exit the spinal cord?

A

thoracolumbar

T1-L3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagram effects of carotid baroreceptors on ANS

A

Draw out slide 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where are the depressor and pressor sensors located?

A

In the medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clicker Q1: Noradrenergic sympathetic neurons run:
A. from nucleus ambiguus to the cranial segments of spinal cord
B. From RVLM to the thoracolumbar segments of the spinal cord
C. from the thoracolumbar segments of the spinal cord to the sympathetic ganglia
D. from the sympathetic ganglia to the effectors organs
E. from the vagus nerve to the heart

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is neurotransmitter from the thoracolumbar segments of the spinal cord to the sympathetic ganglia?

A

ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which one of the following features do the SANS and the PANS share in common?
A. both orig in same nuc w/in medulla
B. both exit spinal cord at the same level
C. both have neurons from the central nervous system to their ganglia that are cholinergic neurons
D. Their post-gang neurons always produce ACh as their neurotransmitter
E. Their shared main purpose is to maintain BP in the face of hypotension or fright

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fill out table for follow SANS vs. PANS

  • -CNS nucleus or origin
  • -exit spinal cord
  • -location of ganglia
  • -length of pre-ganglionic fibers
  • -length of post-ganglionic fibers
  • -Ganglionic transmitter
  • -Ganglionic receptor

Postganglionic fibers release

Tissues with receptors but no innervation

A

see slide 12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NANC (nonadrenergic/noncholinergic) system

A

nerve fibers assoc’d w/ autonomic nerves that release purines or peptides NOT NE or ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the different cholinoreceptors in the peripheral nervous system?

A

Muscarinic: M1, M2, M3

Nicotinic: N_n, (nerve) N_m (NMJ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

M1 receptor

  • location
  • mechanism
  • 2nd messanger
  • action
A

M1 receptor

  • location: nerve endings
  • mechanism: Gq-coupled
  • 2nd messanger: IP3/DAG cascade via Ca2+ release from SER
  • action: activates myenteric pleux
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

M2 receptor

  • location
  • mechanism
  • 2nd messanger
  • action
A

M2

  • location: heart, some nerve endings
  • mechanism: Gi-coupled
  • 2nd messanger: decr cAMP, activate K+ channels
  • action: slow SA node
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

M3 receptor

  • location
  • mechanism
  • 2nd messanger
  • action
A

M3

  • location: smooth muscle, glands, endothelium
  • mechanism: Gq-coupled
  • 2nd messanger: IP3/DAG cascade via Ca2+ release from SER
  • action: contract detrusor muscle; incr salivation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

N_N receptors

  • location
  • mechanism
  • 2nd messanger
  • action
A

N_N

  • location: ANS ganglia
  • mechanism: Na-K ion channel
  • 2nd messanger: Na+
  • action: depolarizes postganglionic fiber/evoking AP
17
Q

N_M

  • location
  • mechanism
  • 2nd messanger
  • action
A

N_M

  • location: neuromuscular end plate
  • mechanism: Na-K ion channel
  • 2nd messanger: Na+
  • action: depolarized muscle cell evoking AP
18
Q

What are the different adrenoreceptors in the SANS?

A 
α1
α2
β1
β2
β3
Dopamine1
19
Q

Draw table listing

  • -location
  • -G prot
  • -2nd messenger
  • -major action

for the different adrenoreceptors in SANS

A

see slide 18

20
Q

What is MOA of sarin gas?

A

AChE inhibitor—>too much ACh

  • bronchorrhea
  • SKM paralysis
21
Q

GPCR anatomy and function

A

Anatomy of a GPRC
–GPCR has 7 membrane-spanning domains; binds ligand

–GPCR is also bound to a G-protein trimer (alpha, beta, gamma subunits) with a bound GDP in membrane

Function:

  • -G-prot swaps GDP for GTPwhen triggered by ligand causing alpha subunit to break away
  • -alpha subunit triggers “specific events”
  • -remaining beta and gamma trigger “general events”

The specificity of the GPCR system depends on the type of alpha subunit:
G_s: stimulates adenylate cyclase—> incr cAMP
G_i: inhibits adenylate cyclas—>decr cAMP
G_q: nothing to do with cAMP; stimulates phospholipase C —> IP3/DAG cascade

22
Q

G_q further mechanism:

A
  • -ligand to GCPR
  • -GDP on alpha_q subunit of G-prot swapped for GTP breaking away
  • -stimulated phospholipase C
  • -phospholipase creates IP3 and DAG
  • —IP3 causing Ca2+ leak from SER; Ca2+ then activates Ca2+-specific protein kinase
  • —DAG activated PKC (prot kinase C)
23
Q

G_s/i further mechanism:

A
  • -ligand to GCPR
  • -GDP on alpha_s/i subunit of G-prot swapped for GTP breaking away
  • -stimulates adenylate cyclase
  • -incr cAMP production
  • -cAMP activates protein kinase A
24
Q

What happens when your BP drops?

A

draw whole slide of 35 w/ attention to autonomic transmission

25
Q 
In order to dilate a pt's pupils as wide as possible, which drug combo?
A. phenylephrine and ACh
B. phenylephrine and atropine
C. phentolamine and ACh
D. phentolamine and atropine
E. isoproterenol and ACh
F. isoproterenol and atropine
A

B

adrengeric agonist: phenylephrine stimulates alpha_1

muscarinic ANTagonist: ACh causes constriction, so atropine blocks muscarinic effects of ACh

26
Q

Norepinephrine (noradrenaline, Levophed™, leave-em-dead during my residency)

Drug Class
PD
PK
Toxicity
Interactions
Special considerations
Indications and dose/route
Monitor
A

Drug class: pharmacologic class—direct-acting, non-specific adrenergic agonist; therapeutic class—vasopressor, vasoconstrictor

Pharmacodynamics: major action is to stimulate peripheral alpha-1 adrenoceptors, thereby leading to vasoconstriction (resistance arterioles, increase SVR) and venoconstriction (in capacitance vessels, increase preload). This increases CO, SVR, and MAP, but decreases blood flow to vulnerable tissues like skin, muscle, and kidney. Also, stimulates beta-1 receptors in the heart, increasing HR and contractility. Main effects are vasoconstriction and cardiac stimulation.

Pharmacokinetics: F ~100%. Given IV only. Metabolized by COMT and MAO, mostly in liver. Metabolites are excreted in urine. Half-life 1-2 minutes (e.g. can be titrated quickly IV). Can cross the placenta, but not the blood/brain barrier.

Toxicity: excessive vasoconstriction in mesenteric vessels, peripheral arterioles causing ischemia, infarction, gangrene; reflex bradycardia

Interactions: use cautiously in patients taking an MAO inhibitor such as phenelzine (use lower doses); risk of excessive hypertension in patients taking propranolol

Special considerations: correct volume depletion with IV fluids BEFORE giving NE infusion; select infusion site carefully—extravasation is a major problem; monitor patient and BP continuously in ICU setting; use cautiously in pediatric and geriatric patients

Indications and dose/route: for adults with acute hypotension and shock (related to low SVR) infuse 2-12 mcg/min

Monitor: BP, HR, infusion site, evidence of extravasation

27
Q

Epinephrine (adrenaline,EpiPen™)

[see RANG 2.03]

Drug Class
PD
PK
Toxicity
Interactions
Special considerations
Indications and dose/route
Monitor
A

Drug class: pharmacologic class—direct-acting, non-selective adrenergic agonist; therapeutic class—vasopressor, cardiac stimulant, bronchodilator, adjunct to local anesthetics, treatment for anaphylaxis

Pharmacodynamics: major action is to stimulate peripheral alpha-1 adrenoceptors, thereby leading to vasoconstriction (resistance arterioles, increase SVR) and venoconstriction (in capacitance vessels, increase preload); beta-1 receptors leading to tachycardia and increased contractility; and beta-2 receptors leading to bronchodilation; these actions are also helpful in severe allergic reactions (e.g. anaphylaxis) by stabilizing mast cells

Pharmacokinetics: can be given iv (immediate), IM (variable), SC 5-15 min), and via inhalation (1-5 min onset), ophthalmic topical; metabolized by COMT and then renally excreted;

Toxicity: excessive vasoconstriction, HTN, hemorrhagic stroke, angina, arrhythmias,
Interactions: risk of excessive hypertension in patients taking propranolol

Special considerations: utility with local anesthetics; drug of choice in severe anaphylactic reactions (along with others)

Indications and dose/route: for anaphylaxis, 0.1-0.5 mg SC or IM; for cardiac arrest, 1-5 mg IV push; for infusion, 1-4 mcg/min; also for allergy-induced asthma

Monitor: BP, HR, rhythm, infusion site, evidence of extravasation

Pharmacology I JXC (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions